Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 21 Genitourinary 10 Breast 10 Gynecologic 6 Plasma cell 5 Thoracic 3 Lymphoid 3 Other hematologic neoplasm 2 Tumor-Agnostic 1 Other 1 Myeloid 1 Head & Neck 1 Dermatologic 1 CNS 1

Conditions

Head and Neck Neoplasms 1

Interventions

Cisplatin 619 pembrolizumab 323 Radiotherapy 319 Cetuximab 274 Docetaxel 220 Radiotherapy, Intensity-Modulated 210 Carboplatin 197 Fluorouracil 196 Paclitaxel 159 Nivolumab 138 Gemcitabine 124 Magnetic Resonance Spectroscopy 94 Radiation 85 Drug Therapy 77 Capecitabine 76 toripalimab 74 Surgical Procedures, Operative 62 durvalumab 60 Biopsy 52 Cyclophosphamide 48 Chemoradiotherapy 47 camrelizumab 46 Specimen Handling 46 Erlotinib Hydrochloride 46 Radiosurgery 45 130-nm albumin-bound paclitaxel 43 tislelizumab 42 Standard of Care 42 Platinum 41 Bevacizumab 40

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Curcumin × Head & Neck × Clear all

NCT04208334 2023-03-28

CurChexia

Phramongkutklao College of Medicine and Hospital

Phase 2 Completed

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡